Trevi Therapeutics (TRVI) Surges as Cash Runway Extends to 2028 After Reporting $194.9M Assets
Trevi Therapeutics, Inc. is a clinical-stage biopharmaceutical company dedicated to developing innovative therapies for some of the most…
Browsing Tag